XML 30 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Equity
$ in Thousands
USD ($)
Capital stock
USD ($)
Capital stock
Common shares
shares
Contributed surplus
USD ($)
Retained earnings
USD ($)
Accumulated 
other 
comprehensive income (loss)
USD ($)
Shareholders’ equity
USD ($)
Non-controlling interests
USD ($)
Balance, beginning of period (in shares) at Dec. 31, 2021 | shares     74,774,087          
Balance, beginning of period at Dec. 31, 2021 $ 1,954,731 $ 432,728   $ 1,928 $ 1,251,640 $ (2,720) $ 1,683,576 $ 271,155
Net income 462,288       353,830   353,830 108,458
Other comprehensive income (loss) 299,447       (252) 299,699 299,447  
Compensation expense recorded for stock options 110     110     110  
Issue of shares on exercise of stock options (in shares) | shares     16,800          
Issue of shares on exercise of stock options 582 582         582  
Reclassification of grant date fair value on exercise of stock options 0 134   (134)        
Sale of partial interest in subsidiary (note 25) 148,990       126,445   126,445 22,545
Payments for repurchase of shares (in shares) | shares     (5,551,751)          
Payments for repurchase of shares (252,985) (32,149)     (220,836)   (252,985)  
Dividend payments to Methanex Corporation shareholders (43,955)       (43,955)   (43,955)  
Distributions made and accrued to non-controlling interests (84,714)             (84,714)
Realized hedge loss (gains) recognized in cash flow hedges (55,037)         (55,037) (55,037)  
Balance, end of period (in shares) at Dec. 31, 2022 | shares     69,239,136          
Balance, end of period at Dec. 31, 2022 2,429,457 401,295   1,904 1,466,872 241,942 2,112,013 317,444
Net income 284,122       174,140   174,140 109,982
Other comprehensive income (loss) (243,542)       (1,976) (241,566) (243,542)  
Compensation expense recorded for stock options 124     124     124  
Issue of shares on exercise of stock options (in shares) | shares     43,067          
Issue of shares on exercise of stock options 1,437 1,437         1,437  
Reclassification of grant date fair value on exercise of stock options 0 190   (190)        
Payments for repurchase of shares (in shares) | shares     (1,894,711)          
Payments for repurchase of shares (86,392) (10,998)     (75,394)   (86,392)  
Dividend payments to Methanex Corporation shareholders (49,378)       (49,378)   (49,378)  
Distributions made and accrued to non-controlling interests (185,336)             (185,336)
Realized hedge loss (gains) recognized in cash flow hedges 22,525         22,525 22,525  
Balance, end of period (in shares) at Dec. 31, 2023 | shares     67,387,492          
Balance, end of period at Dec. 31, 2023 $ 2,173,017 $ 391,924   $ 1,838 $ 1,514,264 $ 22,901 $ 1,930,927 $ 242,090